Business Context and Reporting Period
Company: Rand Capital Corporation (RAND)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2014
Business Model: Rand is an internally managed, closed-end Business Development Company (BDC) and Small Business Investment Company (SBIC). It invests primarily in early-stage and expansion-stage small and medium-sized companies in the United States, focusing on New York and surrounding states. The portfolio consists of a mix of debt and equity instruments, often with warrants or conversion rights.
Key Financial Metrics
| Metric | 2014 | 2013 |
|---|---|---|
| Total Assets | $45,525,987 | $39,750,370 |
| Total Liabilities | $13,172,546 | $11,681,038 |
| Net Assets | $32,353,441 | $28,069,332 |
| Net Asset Value (NAV) per Share | $5.11 | $4.38 |
| Investment Income | $2,584,475 | $2,451,036 |
| Total Expenses | $2,499,297 | $2,359,252 |
| Net Investment Gain (Loss) | $21,835 | $154,478 |
| Net Realized Gain on Investments | $4,767,484 | $4,374,354 |
| Net Increase in Net Assets from Operations | $4,541,481 | $2,873,357 |
| Cash and Cash Equivalents | $13,230,717 | $9,764,810 |
| SBA Debentures (Debt) | $8,000,000 | $7,000,000 |
Material Changes vs. Prior Period
- Net Asset Value Growth: NAV per share increased 15% to $5.11, driven primarily by significant realized gains from portfolio exits.
- Portfolio Activity: The company made $6.3 million in new investments across 14 businesses (7 new companies) and executed three divestitures. The portfolio grew to 29 active businesses valued at $30.3 million.
- Realized Gains: Net realized gains increased to $4.77 million (from $4.37 million in 2013). This was largely due to the sale of BinOptics Corporation, which generated a realized gain of $8.33 million (including $1.51 million held in escrow).
- Unrealized Appreciation: Net unrealized appreciation decreased by $247,838, compared to a decrease of $1.66 million in 2013. This was due to valuation adjustments on several portfolio companies (e.g., Knoa Software, Mezmeriz, CrowdBouncer) offset by gains on others.
- Leverage: SBA leverage increased by $1.0 million to $8.0 million, resulting in a 41% increase in SBA interest expense.
- Liquidity: Cash balances increased by approximately $3.5 million to $13.2 million, representing 41% of net assets (up from 35% in 2013).
Guidance, Outlook, and Risks
Outlook and Management Commentary: Management expressed confidence in the ability to grow the portfolio, citing improving U.S. economic conditions and low costs of capital. With $13.2 million in cash and authorized share repurchases, the company plans to continue adding new investments and reinvesting in existing portfolio companies. Management noted that increased scale allows for larger investments, potentially accelerating growth.
Risks and Contingencies:
- Valuation Risk: 98% of the portfolio consists of private securities without a public market. Valuations are determined in good faith by management and may differ significantly from actual liquidation values.
- Concentration Risk: The top five portfolio companies represented 38% of total assets at year-end. A default or poor performance by any single company could materially impact Net Asset Value.
- Liquidity Risk: Investments are illiquid and subject to resale restrictions. The company may not be able to dispose of securities at advantageous times.
- Regulatory Risk: As a BDC and SBIC, the company is subject to strict regulations by the SEC and SBA, including leverage limits and asset qualification requirements.
- Key Personnel: Success is heavily dependent on two senior officers; the company does not maintain key man life insurance.
Unusual Items: The company recognized a realized loss of $778,253 on EmergingMed.com, Inc., which was sold with no proceeds received. Additionally, a portion of the BinOptics sale proceeds ($1.51 million) remains in escrow until 2016.
Investor Verification Checklist
- Escrow Receivables: Verify the status and release schedule of the $1.51 million escrow from the BinOptics sale and the remaining Ultra-Scan escrow.
- Valuation Methodology: Review the specific inputs used for Level 3 fair value measurements, particularly for the top five holdings which comprise 38% of assets.
- Dividend Policy: Confirm the company's stance on dividends; no cash dividends were paid in 2013 or 2014, and none are intended for 2015.
- Share Repurchase Program: Monitor the execution of the authorized repurchase of up to 1,000,000 shares (465,504 remaining as of year-end) and its impact on NAV.
- SBA Compliance: Ensure continued compliance with SBA leverage and "smaller enterprise" investment requirements to maintain access to government-guaranteed debentures.